EXECUTIVE ENGAGEMENTS
POOL
3581
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
643
Interactions with Platform & by Email
PARTICIPANTS
107
Unique # Participated
VALIDATIONS
31
Responses Validated*
COMPANIES
11
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
179
EDITION
7
PRICE
USD 4950
CODE
MCP10953
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Cell Viability Assays estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at aCAGR of 7% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6% CAGR for the next 7-year period.
The Cell Viability Assays market in the U.S. is estimated at US$864.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$821.8 Million by the year 2027 trailing a CAGR of 6.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.
SELECT PLAYERS
Abcam PLC; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; BioTek Instruments, Inc.; Biotium, Inc.; Creative Bioarray; Danaher Corporation; GE Healthcare; Merck KgaA; PerkinElmer, Inc.; Promega Corporation; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications, Other Applications) » End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital and Diagnostic Laboratories, Other End-Uses) » Product Type (Consumables, Instruments)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Cell Viability Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cell Viability Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cell Viability Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Basic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Stem Cell Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Clinical & Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Clinical & Diagnostic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Clinical & Diagnostic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Cell Viability Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cell Viability Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cell Viability Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Cell Viability Assays by Product Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Cell Viability Assays by Product Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Cell Viability Assays by Product Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Cell Viability Assays by Application - Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Cell Viability Assays by Application - Percentage Breakdown of Value Sales for Basic Research, Stem Cell Research, Drug Discovery & Development, Clinical & Diagnostic Applications and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Cell Viability Assays by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Cell Viability Assays by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospital & Diagnostic Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 11 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com